{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262943775165056.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ijrobp.2009.03.073"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301609008591?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301609008591?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"19735863"}}],"dc:title":[{"@value":"Radiation Therapy for Esophageal Cancer in Japan: Results of the Patterns of Care Study 1999–2001"}],"description":[{"notation":[{"@value":"To describe patient characteristics and the process of radiotherapy (RT) for patients with esophageal cancer treated between 1999 and 2001 in Japan.The Japanese Patterns of Care Study (PCS) Working Group conducted a third nationwide survey of 76 institutions. Detailed information was accumulated on 621 patients with thoracic esophageal cancer who received RT.The median age of patients was 68 years. Eighty-eight percent were male, and 12% were female. Ninety-nine percent had squamous cell carcinoma histology. Fifty-five percent had the main lesion in the middle thoracic esophagus. Fourteen percent had clinical Stage 0-I disease, 32% had Stage IIA-IIB, 43% had Stage III, and 10% had Stage IV disease. Chemotherapy was given to 63% of patients; 39% received definitive chemoradiotherapy (CRT) without surgery and 24% pre- or postoperative CRT. Sixty-two percent of the patients agedor =75 years were treated with RT only. Median total dose of external RT was 60 Gy for definitive CRT patients, 60 Gy for RT alone, and 40 Gy for preoperative CRT.This PCS describes general aspects of RT for esophageal cancer in Japan. Squamous cell carcinoma accounted for the majority of patients. The standard total external RT dose for esophageal cancer was higher in Japan than in the United States. Chemoradiotherapy had become common for esophageal cancer treatment, but patients agedor =75 years were more likely to be treated by RT only."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262943775165184","@type":"Researcher","foaf:name":[{"@value":"Masahiro Kenjo"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165056","@type":"Researcher","foaf:name":[{"@value":"Takashi Uno"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165060","@type":"Researcher","foaf:name":[{"@value":"Yuji Murakami"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165057","@type":"Researcher","foaf:name":[{"@value":"Yasushi Nagata"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165059","@type":"Researcher","foaf:name":[{"@value":"Masahiko Oguchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165061","@type":"Researcher","foaf:name":[{"@value":"Susumu Saito"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165062","@type":"Researcher","foaf:name":[{"@value":"Hodaka Numasaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165058","@type":"Researcher","foaf:name":[{"@value":"Teruki Teshima"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943775165185","@type":"Researcher","foaf:name":[{"@value":"Michihide Mitsumori"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03603016"}],"prism:publicationName":[{"@value":"International Journal of Radiation Oncology*Biology*Physics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2009-10","prism:volume":"75","prism:number":"2","prism:startingPage":"357","prism:endingPage":"363"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0360301609008591?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0360301609008591?httpAccept=text/plain"}],"createdAt":"2009-09-06","modifiedAt":"2018-12-17","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Esophageal%20Neoplasms","dc:title":"Esophageal Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Radiotherapy","dc:title":"Radiotherapy"},{"@id":"https://cir.nii.ac.jp/all?q=Adenocarcinoma","dc:title":"Adenocarcinoma"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Combined%20Modality%20Therapy","dc:title":"Combined Modality Therapy"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Adenosquamous","dc:title":"Carcinoma, Adenosquamous"},{"@id":"https://cir.nii.ac.jp/all?q=Japan","dc:title":"Japan"},{"@id":"https://cir.nii.ac.jp/all?q=Health%20Care%20Surveys","dc:title":"Health Care Surveys"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Squamous%20Cell","dc:title":"Carcinoma, Squamous Cell"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Staging","dc:title":"Neoplasm Staging"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232209035776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hyperfractionated Concomitant Boost Proton Beam Therapy for Esophageal Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232485379200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Intrafraction esophageal motion in patients with clinical T1N0 esophageal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234638839552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690943631872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-Term Results of Radiochemotherapy for Solitary Lymph Node Metastasis After Curative Resection of Esophageal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706274896896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707185739264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"National Medical Care System May Impede Fostering of True Specialization of Radiation Oncologists: Study Based on Structure Survey in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181251607936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568465881059328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of the effects of radiotherapy doses of 50.4 Gy and 60 Gy on outcomes of chemoradiotherapy for thoracic esophageal cancer: subgroup analysis based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656228858112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657139509376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Detection of Esophageal Fiducial Marker Displacement During Radiation Therapy With a 2-dimensional On-board Imager: Analysis of Internal Margin for Esophageal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363104598395769984","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Outcomes of patients with stage IVA esophageal cancer (Japanese classification) treated with definitive chemoradiotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205216053504","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison of Chemoradiotherapy with Radiotherapy Alone in Patients with Esophageal Adenocarcinoma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2009.03.073"},{"@type":"OPENAIRE","@value":"doi_dedup___::e0941e2b087a509cbf4b616796e6759e"},{"@type":"CROSSREF","@value":"10.1269/jrr.10166_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1093/jrr/rrt002_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2011.06.1978_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2011.01.029_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2012.07.2358_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1007/s10147-011-0254-y_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1007/s10147-011-0264-9_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1007/s10388-019-00711-x_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1007/s10147-015-0872-x_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1016/j.rpor.2018.07.013_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2011.02.041_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"},{"@type":"CROSSREF","@value":"10.1007/s11604-013-0180-1_references_DOI_Lq4nRGIxoEM4K5vrWKUzXhrxm3Z"}]}